Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1998-11-10
1999-10-19
Henley, III, Raymond
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514382, 514456, A61K 3144, A61K 3141, A61K 3135
Patent
active
059689595
ABSTRACT:
A method for the prevention and treatment of stunning of the heart subsequent to ischemia-reperfusion is described. The method comprises administering a therapeutically effective amount of a phospholamban inhibitor to a patient. Phospholamban inhibitors relieve the inhibitory effect of phospholamban on cardiac sarcoplasmic reticulum Ca.sup.2+ -ATPase.
REFERENCES:
patent: 3259635 (1966-07-01), Ritter et al.
patent: 3515721 (1970-06-01), Ritter et al.
patent: 4349566 (1982-09-01), della Valle
patent: 4452811 (1984-06-01), della Valle
Ferrari, B., et al., "Development of Tetrazole Bioisosteres in Angiotensin II Antagonists," Bioorg. & Med. Chem. Lett. 4(1):45-50 (1994).
Gao, Y., et al., "Interaction of calmodulin with phospholamban and caldesmon: comparative studies by .sup.1 H-NMR spectroscopy," Biochim. Biophys. Acta 1160:22-34 (1992).
Hoh, J.F.Y., "Muscle fiber types and function," Curr. Opin. Rheum. 4:801-808 (1992).
Kohara, Y., et al., "Synthesis and Angiotensin II Receptor Antagonistic Activities of Benzimidazole Derivatives Bearing Acidic Heterocycles as Novel Tetrazole Bioisosteres," J. Med. Chem. 39:5228-5235 (Dec. 1996).
Lalli, J., et al., "Targeted Ablation of the Phospholamban Gene Is Associated With a Marked Decrease in Sensitivity in Aortic Smooth Muscle, " Circ. Res. 80(4):506-513 (Apr. 1997).
Lindemann, J.P., et al., ".beta.-Adrenergic Stimulation of Phospholamban Phosphorylation and Ca.sup.2+ --ATPase Activity in Guinea Pig Ventricles," J. Biol. Chem. 258(1):464-471 (1983).
Marban, E., "Myocardial Stunning and Hibernation: The Physiology Behind the Colloquialisms," Circulation 83(2):681-688 (1991).
O'Neil, K.T., and DeGrado, W.F., "How calmodulin binds its targets: sequence independent recognition of amphiphilic .alpha.-helices," Trends Biochem. Sci. 15:59-64 (1990).
STN Database CAPLUS, Document No. 77:88302, Murakami, M., et al., "Bis(carboxymethoxy)-4-methylcoumarins," (1972).
STN Database CAPLUS, Document No. 114:42491, Verma, B.S., et al., "Studies of pesticides based on coumarin: Part 5. Synthesis and antifungal activity of substituted 2,3-dihydrocyclopenta[c][1] benzopyran-4(H)-ones," (1989).
STN Database CAPLUS, Document No. 97:216033, Winter, W., et al., "Tricyclic aryl ethers and medicines containing these compounds," (1982).
STN Database CAPLUS, Document No. 97:216005, Lesher, G.Y., and Philion, R.E., "3-Substituted-6-(lower alkyl)-5-(pyridinyl)-2(1H)-pyridinones, their cardiotonic use and intermediates therefor," (1982).
STN Database CAPLUS, Document No. 84:179971, Bartl, K., et al., "Synthesis of .DELTA.8-tetrahydrodibenzo[b,d]pyran-6-ones and their aminolysis to .DELTA.8-tetrahydrophenanthridine-6-ones," (1976).
STN Database CAPLUS, Document No. 84:179968, Chebaane, K., et al., "Synthesis of 2-arylnaphthalenes and of dibenzocoumarins. I. Synthesis of tetrahydrodibenzocoumarins, 2-(1-cyclohexenyl)naphthalenes and tetrahydrobenzocoumarins," (1975).
Haikala Heimo
Kaheinen Petri
Kaivola Juha
Levijoki Jouko
Ovaska Martti
Henley III Raymond
Orion Corporation
LandOfFree
Method for the prevention and treatment of stunned myocardium does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for the prevention and treatment of stunned myocardium, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for the prevention and treatment of stunned myocardium will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2055825